Home › Funds › MONIMUS CAPITAL MANAGEMENT, LP › ASMB
MONIMUS CAPITAL MANAGEMENT, LP position in ASMB
ASSEMBLY BIOSCIENCES INC · Health Care
MONIMUS CAPITAL MANAGEMENT, LP reported holding 47,580 shares of ASMB (ASSEMBLY BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.27% of its reported portfolio and ranking #50 among its reported holdings. MONIMUS CAPITAL MANAGEMENT, LP has disclosed ASMB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MONIMUS CAPITAL MANAGEMENT, LP's ASMB position evolved
MONIMUS CAPITAL MANAGEMENT, LP first disclosed a stake in ASMB in Q4 2024 at 42,067 shares (US$664K). The position peaked in Q1 2026 at 48,390 shares, worth US$1.3M. Across 8 filings, MONIMUS CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 47,580 shares valued at US$1.1M. Notable position changes include a 26% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 42.07K | $663.82K | New |
| Q1 2025 | 42.07K | $402.16K | Hold |
| Q2 2025 | 42.07K | $762.25K | Hold |
| Q3 2025 | 42.07K | $1.08M | Hold |
| Q4 2025 | 38.30K | $1.30M | Reduce |
| Q1 2026 | 48.39K | $1.34M | Add |
| Q2 2026 | 47.58K | $1.31M | Reduce |
| Q3 2026 | 47.58K | $1.12M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ASMB and 13F data
ASMB (ASSEMBLY BIOSCIENCES INC) is a Health Care company. 54 other funds we track also report a position in ASMB — the largest reported positions include GILEAD SCIENCES, INC. (US$116.9M), Farallon Capital Management (US$44.1M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$37.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ASMB
- GILEAD SCIENCES, INC. 4.98M sh · $116.91M · Q3 2026
- Farallon Capital Management 1.60M sh · $44.09M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.60M sh · $37.69M · Q3 2026
- Paradigm Biocapital Advisors LP 1.55M sh · $36.50M · Q3 2026
- Parkman Healthcare Partners LLC 796.26K sh · $18.70M · Q3 2026
- Commodore Capital LP 461.92K sh · $10.85M · Q3 2026
- Seven Fleet Capital Management LP 417.44K sh · $9.81M · Q3 2026
- DV EQUITIES, LLC 226.41K sh · $5.32M · Q3 2026
- Squadron Capital Management LLC 225.00K sh · $5.29M · Q3 2026
- B Group, Inc. 175.71K sh · $4.13M · Q3 2026
More on MONIMUS CAPITAL MANAGEMENT, LP
FAQ
How long has MONIMUS CAPITAL MANAGEMENT, LP held ASMB?
MONIMUS CAPITAL MANAGEMENT, LP has disclosed ASMB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is MONIMUS CAPITAL MANAGEMENT, LP's current position in ASMB?
As of Q3 2026, MONIMUS CAPITAL MANAGEMENT, LP holds 47.58K shares of ASMB (ASSEMBLY BIOSCIENCES INC), valued at $1.12M, representing 0.27% of its reported portfolio and ranking #50.
Has MONIMUS CAPITAL MANAGEMENT, LP been buying or selling ASMB?
In the latest 13F filing (Q3 2026), MONIMUS CAPITAL MANAGEMENT, LP held unchanged its position in ASMB. The position peaked in Q1 2026 at 48.39K shares.
Which other funds hold ASMB?
Other major institutional holders of ASMB include GILEAD SCIENCES, INC., Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.